NCT06546111View on ClinicalTrials.gov

Clinical Study to Evaluate the Possible Efficacy and Safety of Diosmin and Hesperidin Combined Therapy in Patients With Helicobacter Pylori Infection

PHASE1/PHASE2RecruitingINTERVENTIONAL
Enrollment

46

Participants

Timeline

Start Date

October 1, 2024

Primary Completion Date

October 1, 2025

Study Completion Date

October 1, 2026

Conditions
Helicobacter Pylori Infection
Interventions
DRUG

Placebo

Drug :placebo tab PO BID for 14 days.

DRUG

Daflon

Daflon 500 mg tab PO BID for 14 days.

Trial Locations (1)

Unknown

RECRUITING

National Liver Institute, Shibīn al Kawm

All Listed Sponsors
lead

Sadat City University

OTHER